China steps up Alzheimer’s, Parkinson’s drug push, looks to TCM

China is intensifying research into new treatments for Alzheimer’s and Parkinson’s diseases to address a growing public health challenge. The aging population has led to a sharp rise in cases, with Parkinson’s cases projected to increase from 3.6 million in 2024 to 10.5 million by 2050. The country is exploring Traditional Chinese Medicine (TCM) as part of its strategy.